Sentence examples for both cell lines demonstrating from inspiring English sources
Furthermore, binding of 111In-Fab and 125In-Fab was blocked by an excess of unlabelled AbD15179 in both cell lines, demonstrating specific binding of the conjugates (Figure 2).
After overnight (16 h) incubation of cells with 50 μM BCS, the molar ratio of GLP1-NH2 to Fc dropped more than 20-fold for both cell lines, demonstrating the utility of the EIA.
Transduction with AdF35/MK or AdF35/Sur but not AdF35/LacZ induced cleavage of PARP and caspase-3 in both cell lines, demonstrating replication-competent Ad achieved apoptotic cell death.
After incubation without serum, both cell lines demonstrated diffuse distribution of RAF throughout the cytoplasm (Fig 8A).
Both cell lines demonstrated collateral sensitivity (2 4-fold) to CXL017 despite the overexpression of Bcl-2 4-fold
As expected, both cell lines demonstrated similar knockdown of endogenous mouse WDR5, with equal transcription of exogenous human WDR5 RNA.
Both cell lines demonstrated a significant 38% increase in vitronectin adhesion when stimulated with 0.1 μg ml−1 LPS (P<0.05 compared to cells treated with culture medium alone).
Both cell lines demonstrate significant apoptosis occurring following treatment with RRR-γ-tocopherol, but much less with the RRR-α-tocopherol treatment.
Both cell lines demonstrated a moderate expression of EGFR, with the radiosensitive S40b cell line expressing higher levels (21.5 fm mg−1 of protein) than the radioresistant MGH-U1 cell line (16.7 fm mg−1 of protein).
Both cell lines demonstrated an enhancement of colonisation potential, which was most marked when cells were injected after 48 h of exposure followed by a 24 or 48 h recovery period.
Interestingly, the clonogenic survival data of β1- and β3-integrin depleted A-172 and U-138 cells questions this hypothesis, because both cell lines demonstrated a great increase in cell killing after irradiation in comparison with untransfected, irradiated or control Duplex II-transfected, irradiated cells.
